Home / Private raises / Stereotaxis, Inc.
Stereotaxis, Inc.
Other Health Care · St. Louis, Missouri · $12.0M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | D (new) | $12.0M | $24.0M | 10 | 506(b) | Debt, Security to be acquired | Nov 9 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Issuer
| Industry | Other Health Care |
| Located | St. Louis, Missouri |
| Entity | Corporation |
| Incorporated | Delaware |
| SEC CIK | 1289340 |
People named in the latest filing
| Name | Role |
|---|---|
| David L. Fischel | Chief Executive Officer and Chairman of the Board |
| Kimberly R. Peery | Chief Financial Officer |
| David W. Benfer | Director |
| Arun S. Menawat, Ph.D. | Director |
| Myriam Curet, M.D. | Director |
| Nachum Shamir | Director |
| Nathan Fischel, M.D. | Director |
| Ross B. Levin | Director |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
